Q32 Bio Inc.
QTTB · XNASCIK 1661998fmd_0PRTAS2V6VZ726TB0S0YDB76T9Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2026, 39 periods
Loading
Latest annual · FY2025
Millions- Total revenues
- 54
- Operating income
- 17
- Net income
- 30
- Free cash flow
- (34)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +155.9%
- Revenue, 5 yearsFY2020 to FY2025
- +81.9%
- Net income, 5 yearsFY2020 to FY2025
- n/m
Q32 Bio Inc. (QTTB) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $53.7 million | $0 | 10-K 2026-03-10 · proof | |
| Operating income | $16.9 million | -$66.1 million | 10-K 2026-03-10 · proof | |
| Net income | $29.8 million | -$47.7 million | 10-K 2026-03-10 · proof | |
| Cash from operating activities | -$33.5 million | -$67.7 million | 10-K 2026-03-10 · proof | |
| Free cash flow | -$33.5 million | -$67.8 million | 10-K 2026-03-10 · proof |
- What was Q32 Bio Inc. (QTTB)'s revenue in fiscal 2025?
- Q32 Bio Inc. (QTTB) reported revenue of $53.7 million for fiscal 2025 (the year ended Dec 31, 2025), against $0 the year before. Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
- What was Q32 Bio Inc. (QTTB)'s operating income in fiscal 2025?
- Q32 Bio Inc. (QTTB) reported operating income of $16.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$66.1 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
- What was Q32 Bio Inc. (QTTB)'s net income in fiscal 2025?
- Q32 Bio Inc. (QTTB) reported net income of $29.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$47.7 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
- What was Q32 Bio Inc. (QTTB)'s cash from operating activities in fiscal 2025?
- Q32 Bio Inc. (QTTB) reported cash from operating activities of -$33.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$67.7 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
- What was Q32 Bio Inc. (QTTB)'s free cash flow in fiscal 2025?
- Q32 Bio Inc. (QTTB) reported free cash flow of -$33.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$67.8 million the year before. Source: the 10-K filed with the SEC on Mar 10, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:QTTB&period_type=annual&limit=5"Information only, not investment advice.